Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
Imetelstat has shown promising results in improving the quality of life for MDS patients by significantly reducing transfusion dependency, a critical consideration in the management of this blood disorder.
Hematology/Oncology April 8th 2024
Healthgrades for Professionals
Explore key points for patient communication on chemotherapy, offering a clear framework to discuss treatment goals, processes, and side effects, enhancing patient understanding and engagement in their care journey.
Hematology/Oncology April 1st 2024
MDLinx
A radiologist’s failure to detect early-stage cancer exemplifies the profound implications of diagnostic accuracy in radiology, emphasizing the necessity for vigilance in interpreting imaging studies to prevent catastrophic outcomes.
The New England Journal of Medicine
In a recent phase 3 trial, the addition of brentuximab vedotin to standard chemotherapy not only achieved a notable improvement in 3-year event-free survival rates for pediatric Hodgkin’s lymphoma patients but also maintained a comparable safety profile, underscoring the therapeutic potential of targeted treatments in this population.
The Supreme Court’s deliberations on the Chevron deference and FDA’s drug approval authority underscore a critical juncture for healthcare delivery and regulatory practices, potentially reshaping physician autonomy and patient care standards.
Journal of Clinical Pathways
In the realm of oncology, AI’s potential to revolutionize patient care is immense, yet its successful integration hinges on stringent safety measures and a commitment to mitigating biases in data.
Hematology/Oncology March 25th 2024